• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Liposomes as targetable drug carriers.

作者信息

Torchilin V P

出版信息

Crit Rev Ther Drug Carrier Syst. 1985;2(1):65-115.

PMID:3913530
Abstract

The general problem of targeted drug transport is critically reviewed and three principle components of targeted systems are discussed: the target, the vector molecule, and the carrier. Different systems of drug targeting are briefly described: local drug application, chemical modification of the drug molecule, physical targeting under the action of pH, temperature, or magnetic field. The idea of a vector molecule is discussed and different methods of vector molecule coupling with the drug are reviewed (direct coupling, coupling via spacer group or polymer molecule, etc.). It is shown that the most promising approach seems to be the use of a drug-containing microcontainer with the vector molecule immobilized on its outer surface. Different types of microcontainers are briefly described: microcapsules, cell hosts, and liposomes. The advantages of liposomes as drug containers are shown and the main problems of their use for drug targeting in vitro and in vivo conditions are discussed. One of the most important problems is the problem of vector molecule immobilization on liposome surfaces. The principle four different immobilization methods: adsorbtion, incorporation, covalent binding, and hydrophobic binding. Targeted liposome transport is described in model systems, cell cultures, and experimental animals. It is shown that targeted liposomes may release a drug via diffusion, lysis, or endocytosis by appropriate cells. The problems of targeted liposome technology and clinical application are analyzed.

摘要

相似文献

1
Liposomes as targetable drug carriers.
Crit Rev Ther Drug Carrier Syst. 1985;2(1):65-115.
2
[Possibility of the unification of directed drug transport as illustrated by liposome transport to target antigens].[以脂质体转运至靶抗原为例说明定向药物转运统一的可能性]
Biull Eksp Biol Med. 1986 Sep;102(9):305-7.
3
Pharmaceutical approaches to colon targeted drug delivery systems.结肠靶向给药系统的药物学方法。
J Pharm Pharm Sci. 2003 Jan-Apr;6(1):33-66.
4
Liposomes and skin: from drug delivery to model membranes.脂质体与皮肤:从药物递送 to 模型膜
Eur J Pharm Sci. 2008 Aug 7;34(4-5):203-22. doi: 10.1016/j.ejps.2008.05.002. Epub 2008 May 8.
5
Polymer-coated long-circulating microparticulate pharmaceuticals.聚合物包衣的长效循环微粒药物。
J Microencapsul. 1998 Jan-Feb;15(1):1-19. doi: 10.3109/02652049809006831.
6
Application of targeted drug delivery system in Chinese medicine.靶向药物输送系统在中药中的应用。
J Control Release. 2009 Sep 1;138(2):103-12. doi: 10.1016/j.jconrel.2009.05.008. Epub 2009 May 9.
7
The potential of liposomes in oral drug delivery.脂质体在口服药物递送中的潜力。
Crit Rev Ther Drug Carrier Syst. 1998;15(5):421-80.
8
Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery.塑料、疏水性和亲水性聚合物作为控释药物递送基质的比较评价。
J Pharm Pharm Sci. 2003 May-Aug;6(2):282-91.
9
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
10
Targeted intracellular delivery of therapeutics: an overview.治疗药物的靶向细胞内递送:综述
Pharmazie. 2007 Sep;62(9):643-58.

引用本文的文献

1
Progress on liposome delivery systems in the treatment of bladder cancer.脂质体递送系统在膀胱癌治疗中的研究进展
RSC Adv. 2025 May 6;15(18):14315-14336. doi: 10.1039/d5ra00746a. eCollection 2025 Apr 28.
2
Vaccine Strategies Against RNA Viruses: Current Advances and Future Directions.针对RNA病毒的疫苗策略:当前进展与未来方向
Vaccines (Basel). 2024 Nov 28;12(12):1345. doi: 10.3390/vaccines12121345.
3
Nanomedicine in Bladder Cancer Therapy.膀胱癌治疗中的纳米医学。
Int J Mol Sci. 2024 Sep 26;25(19):10388. doi: 10.3390/ijms251910388.
4
Metal-Organic Frameworks for Overcoming the Blood-Brain Barrier in the Treatment of Brain Diseases: A Review.用于克服血脑屏障治疗脑部疾病的金属有机框架:综述
Nanomaterials (Basel). 2024 Aug 23;14(17):1379. doi: 10.3390/nano14171379.
5
Nanoscale strides: exploring innovative therapies for breast cancer treatment.纳米尺度的进展:探索乳腺癌治疗的创新疗法。
RSC Adv. 2024 Apr 29;14(20):14017-14040. doi: 10.1039/d4ra02639j. eCollection 2024 Apr 25.
6
Nanomedicine in therapeutic warfront against estrogen receptor-positive breast cancer.纳米医学在对抗雌激素受体阳性乳腺癌的治疗前沿
Drug Deliv Transl Res. 2023 Jun;13(6):1621-1653. doi: 10.1007/s13346-023-01299-7. Epub 2023 Feb 16.
7
Enhanced Efficacy of Radiopharmaceuticals When Using Technetium-99m-Labeled Liposomal Agents: Synthesis and Pharmacokinetic Properties.使用锝-99m标记的脂质体药物时放射性药物的增强疗效:合成与药代动力学特性
Biomedicines. 2022 Nov 21;10(11):2994. doi: 10.3390/biomedicines10112994.
8
Nanotechnology for angiogenesis: opportunities and challenges.纳米技术促进血管生成:机遇与挑战。
Chem Soc Rev. 2020 Jul 21;49(14):5008-5057. doi: 10.1039/c8cs01021h. Epub 2020 Jun 15.
9
Integrating nanomedicine into clinical radiotherapy regimens.将纳米医学整合到临床放射治疗方案中。
Adv Drug Deliv Rev. 2019 Apr;144:35-56. doi: 10.1016/j.addr.2019.07.002. Epub 2019 Jul 4.
10
The use of nanoparticulates to treat breast cancer.纳米粒子在乳腺癌治疗中的应用。
Nanomedicine (Lond). 2017 Oct;12(19):2367-2388. doi: 10.2217/nnm-2017-0202. Epub 2017 Sep 4.